Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors

Nucleic acid therapeutics are used for silencing, expressing or editing genes in vivo. However, their systemic stability and targeted delivery to bone marrow resident cells remains a challenge. In this study we present a nanotechnology platform based on natural lipoproteins, designed for delivering small interfering RNA (siRNA), antisense oligonucleotides and messenger RNA to myeloid cells and haematopoietic stem and progenitor cells in the bone marrow. We developed a prototype apolipoprotein nanoparticle (aNP) that stably incorporates siRNA into its core. We then created a comprehensive library of aNP formulations and extensively characterized their physicochemical properties and in vitro performance. From this library, we selected eight representative aNP-siRNA formulations and evaluated their ability to silence lysosomal-associated membrane protein 1 (Lamp1) expression in immune cell subsets in mice after intravenous administration. Using the most effective aNP identified from the screening process, we tested the platform's potential for therapeutic gene silencing in a syngeneic murine tumour model. We also demonstrated the aNP platform's suitability for splice-switching with antisense oligonucleotides and for protein production with messenger RNA by myeloid progenitor cells in the bone marrow. Our data indicate that the aNP platform holds translational potential for delivering various types of nucleic acid therapeutics to myeloid cells and their progenitors.

Authors

Institutions

Publication Details

Journal
Nature Nanotechnology
Published
2025-02-03
DOI
https://doi.org/10.1038/s41565-024-01847-3
Citations
37
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
29.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors

Jeroen Deckers, Thijs J. Beldman, Eliane E.S. Brechbühl, Y. Darwish et al.
37 citations
Nature Nanotechnology
RNA Interference and Gene Delivery
29.82
article

Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors

Jeroen Deckers, Thijs J. Beldman, Eliane E.S. Brechbühl, Y. Darwish, Mihai Gheorghe Netea, Mirre M. Trines, David P. Schrijver, Tommaso Tabaglio, Willem J. M. Mulder, Ewelina Kluza, Roy van der Meel, Tom Anbergen, Yuri van Elsas, Gloria Ros, Anne de Dreu, Yohana Camila Antunes Frederico, Stijn R. J. Hofstraat, Abraham J. P. Teunissen, Pieter Vader, Henk M. Janssen, Bram Priem, Olivier G. de Jong, Robby Zwolsman, Teun Kleuskens, Lars M. Verhalle, Willem Tielemans, Daniek Hoorn, Francisca Borges, M. Hendrikx, Rianne Maas, Peter Fransen, Dave Keng Boon Wee, Iris Versteeg, Branca M. Bartelet
article en
37 citations

Abstract

Nucleic acid therapeutics are used for silencing, expressing or editing genes in vivo. However, their systemic stability and targeted delivery to bone marrow resident cells remains a challenge. In this study we present a nanotechnology platform based on natural lipoproteins, designed for delivering small interfering RNA (siRNA), antisense oligonucleotides and messenger RNA to myeloid cells and haematopoietic stem and progenitor cells in the bone marrow. We developed a prototype apolipoprotein nanoparticle (aNP) that stably incorporates siRNA into its core. We then created a comprehensive library of aNP formulations and extensively characterized their physicochemical properties and in vitro performance. From this library, we selected eight representative aNP-siRNA formulations and evaluated their ability to silence lysosomal-associated membrane protein 1 (Lamp1) expression in immune cell subsets in mice after intravenous administration. Using the most effective aNP identified from the screening process, we tested the platform's potential for therapeutic gene silencing in a syngeneic murine tumour model. We also demonstrated the aNP platform's suitability for splice-switching with antisense oligonucleotides and for protein production with messenger RNA by myeloid progenitor cells in the bone marrow. Our data indicate that the aNP platform holds translational potential for delivering various types of nucleic acid therapeutics to myeloid cells and their progenitors.

Nature NanotechnologyVol. 20(4)
NXP (Netherlands) (NL), Agency for Science, Technology and Research (SG), University of Bonn (DE), Radboud University Nijmegen (NL), Utrecht University (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), Radboud Institute for Molecular Life Sciences (NL), SyMO-Chem (Netherlands) (NL), Institute of Molecular and Cell Biology (SG), Eindhoven University of Technology (NL), Icahn School of Medicine at Mount Sinai (US)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Openalex Percentile: Top 0%
RNA Interference and Gene Delivery
29.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.